Functional E3 ligase hotspots and resistance mechanisms to small-molecule degraders

被引:54
|
作者
Hanzl, Alexander [1 ]
Casement, Ryan [2 ]
Imrichova, Hana [1 ]
Hughes, Scott J. [2 ,3 ]
Barone, Eleonora [1 ]
Testa, Andrea [2 ,3 ]
Bauer, Sophie [1 ,4 ]
Wright, Jane [2 ]
Brand, Matthias [1 ,4 ]
Ciulli, Alessio [2 ]
Winter, Georg E. [1 ]
机构
[1] Austrian Acad Sci, CeMM Res Ctr Mol Med, Vienna, Austria
[2] Univ Dundee, James Black Ctr, Sch Life Sci, Div Biol Chem & Drug Discovery, Dundee, Scotland
[3] Amphista Therapeut Ltd, Newhouse, Scotland
[4] Proxygen GmbH, Vienna, Austria
基金
欧洲研究理事会; 英国惠康基金; 奥地利科学基金会; 英国生物技术与生命科学研究理事会;
关键词
TARGETED PROTEIN-DEGRADATION; UBIQUITIN LIGASE; STRUCTURAL BASIS; IDENTIFICATION; OPTIMIZATION; INHIBITORS; TOOLKIT; DESIGN;
D O I
10.1038/s41589-022-01177-2
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
Targeted protein degradation is a novel pharmacology established by drugs that recruit target proteins to E3 ubiquitin ligases. Based on the structure of the degrader and the target, different E3 interfaces are critically involved, thus forming defined 'functional hotspots'. Understanding disruptive mutations in functional hotspots informs on the architecture of the assembly, and highlights residues susceptible to acquire resistance phenotypes. Here we employ haploid genetics to show that hotspot mutations cluster in substrate receptors of hijacked ligases, where mutation type and frequency correlate with gene essentiality. Intersection with deep mutational scanning revealed hotspots that are conserved or specific for chemically distinct degraders and targets. Biophysical and structural validation suggests that hotspot mutations frequently converge on altered ternary complex assembly. Moreover, we validated hotspots mutated in patients that relapse from degrader treatment. In sum, we present a fast and widely accessible methodology to characterize small-molecule degraders and associated resistance mechanisms.
引用
收藏
页码:323 / +
页数:26
相关论文
共 50 条
  • [21] QSAR modeling and in silico design of small-molecule inhibitors targeting the interaction between E3 ligase VHL and HIF-1α
    Pan, Jing
    Zhang, Yanmin
    Ran, Ting
    Xu, Anyang
    Qiao, Xin
    Yin, Lingfeng
    Zhou, Weineng
    Zhu, Lu
    Zhao, Junnan
    Lu, Tao
    Chen, Yadong
    Jiang, Yulei
    MOLECULAR DIVERSITY, 2017, 21 (03) : 719 - 739
  • [22] Activation mechanisms of the E3 ubiquitin ligase parkin
    Panicker, Nikhil
    Dawson, Valina L.
    Dawson, Ted M.
    BIOCHEMICAL JOURNAL, 2017, 474 : 3075 - 3086
  • [23] Design, Synthesis, and Biological Evaluation of HDAC Degraders with CRBN E3 Ligase Ligands
    Lu, Yingxin
    Sun, Danwen
    Xiao, Donghuai
    Shao, Yingying
    Su, Mingbo
    Zhou, Yubo
    Li, Jia
    Zhu, Shulei
    Lu, Wei
    MOLECULES, 2021, 26 (23):
  • [24] Functional dissection of a HECT ubiquitin E3 ligase
    Lu, Jin-Ying
    Lin, Yu-Yi
    Oian, Jiang
    Tao, Sheng-Ce
    Zhu, Jian
    Pickart, Cecile
    Zhu, Heng
    MOLECULAR & CELLULAR PROTEOMICS, 2008, 7 (01) : 35 - 45
  • [25] Methodology for the identification of small molecule inhibitors of the Fanconi Anaemia ubiquitin E3 ligase complex
    Sharp, Michael F.
    Murphy, Vince J.
    Van Twest, Sylvie
    Tan, Winnie
    Lui, Jennii
    Simpson, Kaylene J.
    Deans, Andrew J.
    Crismani, Wayne
    SCIENTIFIC REPORTS, 2020, 10 (01)
  • [26] Methodology for the identification of small molecule inhibitors of the Fanconi Anaemia ubiquitin E3 ligase complex
    Michael F. Sharp
    Vince J. Murphy
    Sylvie Van Twest
    Winnie Tan
    Jennii Lui
    Kaylene J. Simpson
    Andrew J. Deans
    Wayne Crismani
    Scientific Reports, 10
  • [27] Hakin-1, a New Specific Small-Molecule Inhibitor for the E3 Ubiquitin-Ligase Hakai, Inhibits Carcinoma Growth and Progression
    Martinez-Iglesias, Olaia
    Casas-Pais, Alba
    Castosa, Raquel
    Diaz-Diaz, Andrea
    Roca-Lema, Daniel
    Concha, Angel
    Cortes, Alvaro
    Gago, Federico
    Figueroa, Angelica
    CANCERS, 2020, 12 (05)
  • [28] Hijacking the E3 ubiquitin ligase cereblon to create efficient BRD4 degraders
    Lu, Jing
    Qian, Yimin
    Altieri, Martha
    Dong, Hanqing
    Wang, Jing
    Raina, Kanak
    Winkler, Jim
    Crew, Andy
    Coleman, Kevin
    Hines, John
    Crews, Craig
    CANCER RESEARCH, 2015, 75
  • [29] Recognition of substrate degrons by E3 ubiquitin ligases and modulation by small-molecule mimicry strategies
    Lucas, Xavier
    Ciulli, Alessio
    CURRENT OPINION IN STRUCTURAL BIOLOGY, 2017, 44 : 101 - 110
  • [30] Discovery of SOCS7 as a versatile E3 ligase for protein-based degraders
    Cornbois, Anais
    Sorbara, Marie
    Cristol, Margot
    Vigne, Emmanuelle
    Cordelier, Pierre
    Desrumeaux, Klervi
    Bery, Nicolas
    ISCIENCE, 2024, 27 (05)